Immunization with alum-collagen II complex suppresses the development of collagen-induced arthritis in rats by deviating the immune response

Scandinavian Journal of Immunology

Volumn 46, Issue 6, 1997, Pages 619-624

  Mattsson, L ^a   Lorentzen, J C ^a   Svelander, L ^a   Bucht, A ^a   Nyman, U ^a   Klareskog, L ^a   Larsson, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; COLLAGEN TYPE 2; IMMUNOGLOBULIN G ANTIBODY;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS;

EID: 0031469316     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-163.x     Document Type: Article

References (31)

1. Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman WJ. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 1989;32:1087-92.
2. Ronnelid J, Lysholm J, Engstrom-Laurent A, Klareskog L, Heyman B. Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum 1994;37:1023-9.
3. Trentham DE. Collagen arthritis as a relevant model for rheumatoid arthritis. (Review). Arthritis Rheum 1982;25:911-16.
4. Klareskog L, Ronnelid J, Holm G. Immunopathogenesis and immunotherapy in rheumatoid arthritis: an area in transition. (Review). J Intern Med 1995;238:191-206.
5. Larsson P, Kleinau S, Holmdahl R, Klareskog L. Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum 1990;33:693-701.
6. Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunology 1996;26:1511-18.
7. Mussener A, Klareskog L, Lorentzen JC, Kleinau S. TNF-alpha dominates cytokine mRNA expression in lymphoid tissues of rats developing collagen- and oil-induced arthritis. Scand J Immunol 1995;42:128-34.
8. Mussener A, Lorentzen JC, Kleinau S, Klareskog L. Altered Th1/ Th2 balance associated with non-major histocompatibility complex genes in collagen-induced arthritis in resistant and non-resistant rat strains. Eur J Immunol 1997;27:695-9.
9. Walmsley M, Katsikis PD, Abney E et al. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 1996;39:495-503.
10. Tanaka Y, Otsuka T, Hotokebuchi T et al. Effect Of IL-10 on collagen-induced arthritis in mice. Inflamm Res 1996;45:283-8.
11. Persson S, Mikulowska A, Narula S, Ogarra A, Holmdahl R. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 1996;44:607-14.
12. Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM. Induction of arthritis with monoclonal antibodies to collagen. J Immunol 1992;148:2103-8.
13. Morgan K, Clague RB, Shaw MJ, Firth SA, Twose TM, Holt PJ. Native type II collagen-induced arthritis in the rat: the effect of complement depletion by cobra venom factor. Arthritis Rheum 1981;24:1356-62.
14. Firth SA, Morgan K, Evans HB, Holt PJ. IgG subclasses in collagen-induced arthritis in the rat. Immunol Lett 1984;7:243-7.
15. Lorentzen JC, Erlandsson H, Mussener A et al. Specific and long-lasting protection from collagen-induced arthritis and oil-induced arthritis in DA rats by administration of immunogens. Scand J Immunol 1995;42:82-9.
16. Yang X, Hayglass KT. Allergen-dependent induction of interleukin-4 synthesis in vivo. Immunology 1993;78:74-9.
17. Takenaka T, Kuribayashi K, Nakamine H et al. Regulation by cytokines of eosinophilopoiesis and immunoglobulin E production in mice. Immunology 1993;78:541-6.
18. Andersson M, Holmdahl R. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 1990;20:1061-6.
19. Smith BD, Martin GR, Miller EJ, Dorfman A, Swarm R. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch Biochem Biophys 1975;166:181-6.
20. Burkhardt H, Holmdahl R, Deutzmann R et al. Identification of a major antigenic epitope on CNBr-fragment 11 of type II collagen recognized by murine autoreactive B cells. Eur J Immunol 1991;21:49-54.
21. Kleinau S, Erlandsson H, Holmdahl R, Klareskog L. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmunity 1991;4:871-80.
22. Bucht A, Larsson P, Weisbrot L et al. Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin Exp Immunol 1996;103:357-67.
23. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD. A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J Immunol Methods 1994;177:23-8.
24. Bruggemann M. Evolution of the rat immunoglobulin gamma heavy-chain gene family. Gene 1988;74:473-82.
25. Binder J, Graser E, Hancock WW et al. Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients. Transplantation 1995;60:1516-24.
26. Der Balian GP, Slack J, Clevinger BL, Bazin H, Davie JM. Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats. J Exp Med 1980;152:209-18.
27. Sayegh MH, Akalin E, Hancock WW et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995;181:1869-74.
28. Maggi E, Parronchi P, Manetti R et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992;148:2142-7.
29. Dechanet J, Rissoan MC, Banchereau J, Miossec P. Interleukin 4, but not interleukin 10. regulates the production of inflammation mediators by rheumatoid synoviocytes. Cytokine 1995;7:176-83.
30. Fenton MJ, Buras JA, Donnelly RP. IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J Immunol 1992;149:1283-8.
31. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992;257:539-42.